Polycystic ovary morphology: age-based ultrasound criteria

Slides:

Advertisements

Similar presentations

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Advertisements

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.

Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice Lysanne.

Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls Lisa E. Kenigsberg,

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Anuja Dokras, M.D., Ph.D., Shailly Saini,

Age at menarche: a predictor of diminished ovarian function?

Soyoung Bae, M.D., Joseph Karnitis, M.D. Fertility and Sterility

Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D

Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women Babak Mokhlesi, M.D.,

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Michael M. Alper, M.D. Fertility and Sterility

Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters Enrico Carmina, M.D., Francesco.

Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Anuja Dokras, M.D., Ph.D., Shailly Saini,

Hepatitis and reproduction

Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome

Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study Angela Kerchner, B.A., Whitney Lester,

Medical treatment of ectopic pregnancy: a committee opinion

Christel Meuleman, M. D. , Birgit Vandenabeele, M. D

Cosmetics use and age at menopause: is there a connection?

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Oocyte cryopreservation

Assisted reproductive technology in the United States: 1999 results generated from the American Society for reproductive medicine/society for assisted.

Epidemiology and Adverse Cardiovascular Disease (CVD) Risk Profile of Polycystic Ovarian Syndrome (PCOS): The Kaiser Permanente Polycystic Ovarian Syndrome.

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.

Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea Hang Wun Raymond Li,

Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular.

Andrew C. Bjonnes, M.S., Richa Saxena, Ph.D., Corrine K. Welt, M.D.

Hyperglycemia Stimulates Activation of Nuclear Factor κB (NFκB) in Mononuclear Cells (MNC) of Women With Polycystic Ovary Syndrome (PCOS) F. Gonzalez,

Increased secretion of amylin in women with polycystic ovary syndrome

Prevalence of polycystic ovary syndrome in adolescents

Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D. Fertility and Sterility

Diagnosis of pituitary gonadotroph adenomas in reproductive-aged women

Michael C. Allemand, M. D. , Ian S. Tummon, M. D. , Jennifer L. Phy, D

P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)

Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D

Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial Antoni J. Duleba, M.D.,

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

S. Samuel Kim, M.D. Fertility and Sterility

Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function S.Samuel Kim, M.D., In-Tak Hwang, M.D.,

Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women.

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Lisa F. Schneider, M. D. , Sara E. Monaco, M. D. , Michelle P

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Relaxin has a role in establishing a renal response in pregnancy

Fertility and Sterility: an evaluation

Paolo Moghetti, M.D. Fertility and Sterility

Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome:

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with.

Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome Yuwen Wu, M.D., Jianhua Zhang,

Current evaluation of amenorrhea

A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child Xin Chen, M.D., M.Sc., Shi-ling Chen,

Inappropriate gonadotropin secretion in polycystic ovary syndrome

Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D

Follicular fluid of single follicles from women with PCOS contains higher levels of müllerian inhibiting substance L.T. Ku, S.T. Nakajima, M.E. McClure,

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Melissa C. Yih, M.D.,

Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D

In vitro sildenafil citrate use as a sperm motility stimulant

Increased risk of depressive disorders in women with polycystic ovary syndrome Elizabeth Hollinrake, B.S., Alison Abreu, M.D., Michelle Maifeld, R.N.C.,

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary)

Ovarian follicular volume and follicular surface area are better indicators of follicular growth and maturation, respectively, than is follicular diameter

Presentation transcript:

Polycystic ovary morphology: age-based ultrasound criteria Hyun-Jun Kim, M.D., Judith M. Adams, D.M.U., Jens A. Gudmundsson, M.D., Gudmundur Arason, M.D., Cindy T. Pau, M.D., Corrine K. Welt, M.D. Fertility and Sterility Volume 108, Issue 3, Pages 548-553 (September 2017) DOI: 10.1016/j.fertnstert.2017.07.005 Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Figure 1 (A) Ovarian volume and (B) follicle number in women with PCOS (open gray circles) and controls (open black squares) as a function of age. Black horizontal lines indicate the chosen cutoff to distinguish PCOM from normal morphology. Fertility and Sterility 2017 108, 548-553DOI: (10.1016/j.fertnstert.2017.07.005) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Figure 2 ROC curves demonstrating the sensitivity and specificity of (A) ovarian volume and (B) follicle number as a single factor to distinguish PCOS subjects from controls for age groups 18–24 (gray circles), 25–29 (open circles), 30–34 (closed triangles), 35–39 (solid line), and 40–44 years (X). Fertility and Sterility 2017 108, 548-553DOI: (10.1016/j.fertnstert.2017.07.005) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions